This is the authors' abstract. We don't add key points for this paper.
Linear IgA bullous dermatosis treated with dupilumab in a pediatric patient with glucose- 6-phosphate dehydrogenase deficiencyTo the Editor: In the recently published article ''Successful treatment of linear immunoglobulin A bullous dermatosis with dupilumab in a pediatric patient,'' Almuhanna et al 1 described the first reported case to date of linear IgA bullous dermatosis (LABD) successfully treated with dupilumab in a 7-year-old patient.We would like to report the second case of childhood LABD successfully treated with dupilumab.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Muzumdar et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: